CARCINOMA IN SITU
Clinical trials for CARCINOMA IN SITU explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA IN SITU trials appear
Sign up with your email to follow new studies for CARCINOMA IN SITU, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Personalized vaccine joins fight against bladder cancer recurrence
Disease control Recruiting nowThis study is testing whether adding a new personalized cancer vaccine called V940 to the standard BCG treatment helps people with high-risk bladder cancer stay cancer-free longer. Researchers will compare the combination of V940 plus BCG against BCG treatment alone in about 308 …
Matched conditions: CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New cancer drug injected directly into tumors enters human testing
Disease control Recruiting nowThis is a first-in-human study to find a safe and effective dose of a new drug called ONM-501. The drug is injected directly into tumors and is being tested alone and in combination with an approved immunotherapy drug (cemiplimab) in adults with advanced cancers that have stopped…
Matched conditions: CARCINOMA IN SITU
Phase: PHASE1 • Sponsor: OncoNano Medicine, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Massive study aims to unlock future cures by tracking 75,000 young cancer patients
Knowledge-focused Recruiting nowThis study is creating a large registry and tissue bank for children and young adults with cancer. It collects health information and leftover tissue samples from patients up to age 25 to help researchers understand these diseases better. The goal is to use this information to im…
Matched conditions: CARCINOMA IN SITU
Sponsor: Children's Oncology Group • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:27 UTC